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Elastin cross-linking in the skin from patients with
amyotrophic lateral sclerosis
Seiitsu Ono, Mitsuo Yamauchi
Abstract
Two cross-links unique to elastin,
desmosine and isodesmosine were mea-
sured and compared in skin tissue (left
upper arm) from 10 patients with amyo-
trophic lateral sclerosis (ALS) and from
seven age-matched controls. The con-
tents of desmosine and isodesmosine
were significantly decreased (p <0*01
and p < 0'01, respectively) in patients
with ALS compared with those of con-
trols, and were negatively and signifi-
cantly associated with duration of illness
in ALS patients (r = -0*77, p < 0'01 and
r = -065, p < 005, respectively). The
decline in skin desmosine and isodesmo-
sine is more rapid in ALS than in normal
ageing. Thus cross-linking of skin elastin
is affected in ALS.
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Several studies have reported an alteration of
skin pathology in amyotrophic lateral sclerosis
(ALS).lA Recently it was found that the colla-
gen content of skin from patients with ALS
was significantly lower than normal,5 and that
there was a decrease in the content of nonre-
ducible, stable cross-link, histidinohydroxy-
lysinonorleucine (HHL) and an increase




duration of illness in the skin collagen of
patients with ALS.6 However, little is known
concerning the biochemical nature of skin
elastin in ALS.
Elastic fibres are found in most connective
tissue with collagen and polysaccharides, and
can stretch to several times their length and
then rapidly return to their original size and
shape when the tension is released. Elastin is
the major component of elastic fibres and
therefore ideally suited for this role partly due
to a series of lysine-derived, covalent cross-
links.7 These cross-links are formed extracel-
lularly and contribute to the remarkable
stability of the elastic fibre. Of these cross-
links, desmosine and its isomer, isodesmo-
sine, are unique to elastin in mammalian
tissues and thereby, provide a specific marker
for this protein.8 Although it is known that
the initial step in elastin cross-linking involves
the conversion of peptidyl lysine to 5-amino-
5-carboxypentanal by the action of lysyl oxi-
dase,9 the detailed mechanism of formation of
desmosine and isodesmosine is still unknown.
Since the same initial step is required in the
formation of collagen cross-links which we
have found to be disrupted in skin tissue in
ALS,6 we have now quantified cross-links of
elastin in skin at various stages of ALS and
compared the results to those of controls.
Patients and methods
PATIENTS
There were 10 patients with ALS (mean age,
59 years; range, 52-66 years) and seven age-
matched controls with other neurological or
muscular diseases (mean age, 61 years; range,
55-71 years). All patients with ALS had the
presence of both upper and lower motor neu-
ron signs, clear evidence of progression, nor-
mal nerve conduction velocities and late
responses, and electromyographic evidence of
diffuse denervation. Evaluation included a
detailed history and physical examination,
and extensive haematological, biochemical,
electrophysiological, and radiological testing.
At least three neurologists agreed on the diag-
nosis in each case. The diagnoses in the
control group were spinocerebellar degenera-
tion, polymyositis, Alzheimer's disease,
Parkinson's disease, cerebral infarction, pro-
gressive muscular atrophy, and myasthenia
gravis in one patient each. Informed consent
was obtained from all patients with ALS and
controls. Punch biopsy specimens of skin
overlying the left biceps were taken following
local anaesthesia with 1% procaine
hydrochloride, and were stored at -80°C
until use.
PREPARATION OF SAMPLES
The skin was carefully trimmed of hair and
subcutaneous fat. All preparations were car-
ried out at 4°C. Samples were pulverised
under liquid nitrogen using a Spex Freezer
Mill (Spex, Metuchen, New Jersey) to a fine
powder, and then washed with cold 0 015 M
N-trishydroxymethyl-2-aminoethanesulfonic
acid (TES) buffer, pH 7-4 to remove some of
the soluble material and serum proteins. The
insoluble fraction was extensively dialysed
against cold distilled water, and lyophilised.
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Statistical comparisons were made by
unpaired Student's t test, with p < 0 05 as the
significance level. Correlation coefficients







Figure 1 The contents of desmosine (A) and isodesmosine (B) in patients with ALSc
control subjects. The contents ofdesmosine and isodesmosine are significandy decreased
patients wnth ALS compared with those of control subjects (p < 0-01 andp < 0-01,
respectively). Bars show mean (SD); dw = dry weight of the sample.
CROSS-LINK ANALYSIS
Cross-links of desmosine and isodesmos
were analysed by quantitative amino a
analysis. The carefully weighed dried s]
powder was hydrolysed with 6N HC1
vacuo in an N, atmosphere for 24 hours
110°C. The hydrolysates were evaporated
speed centrifugation (Savant Instrumen
and the residues were dissolved in 0-5-1-0
of distilled water. After the sample solut
was filtered, desmosine and isodesmos
contents of each sample were directly quar
fied by an amino acid analyser (Varian 55
liquid chromatography, AA9 11 colun
Interaction). The ninhydrin reactant v
monitored by absorbance at 570 nm
desmosine and isodesmosine. The ninhyd
colour factors for desmosine and isodesn
sine were determined based on the standa
which were commercially obtained (Elas
Products Company). The values of desn
sine and isodesmosine were expressed



























Duration of disease (years
Figure 2 Correlation ofduration of illness to the contents ofdesmosine (A) and
isodesmosine (B) in patients with ALS. The contents of desmosine and isodesmosine are
plotted as a function of duration of illness. There is a significant negative relationship
between the contents ofdesmosine and isodesmosine, and duration of illness (r = 0-77
p < 0-01 and r = - 065, p < 0-05, respectively); dw = d?y weight of the sample.
Results
The contents of desmosine and isodesmosine
were significantly decreased (p < 0 01 and
p < 0.01, respectively) in patients with ALS
[mean (SD) 0 94 (0-33) and 0-74 (0 30)
nmoles/mg dry weight; range, 0-36-1-51 and
0-29-1 33 nmoles/mg dry weight, respec-
tively] compared with those of controls [mean
(SD) 1-43 (0-30) and 1-19 (0-21) nmoles/mg
B dry weight; range, 1-11-2-03 and 0-92-1-52
nmoles/mg dry weight, respectively] (fig 1).
The contents of desmosine and isodesmosine
ad were negatively and significantly associated
with the duration of illness in patients with
ALS (r = -0-77, p < 0-01 and r = -0-65,
p < 0-05, respectively) (fig 2). These data
indicated that the amount of mature cross-
links of elastin decreased as a function of
duration of disease in ALS. The ratio of
ine desmosine and isodesmosine was relatively
cid constant [mean (SD) 1-29 (0-31); range,
kin 1-18-1-41] and there was no significant
in change in the proportion of these two cross-
at links in all samples analysed. These ratios






00 It was reported that the amount of desmosine
nn, and isodesmosine decreased in elastins iso-
was lated from both aortas and pulmonary tissues
for of humans with increasing age.11 In our study
Irin it was demonstrated that the content of
no- desmosine and isodesmosine in ALS patients
rds decreased with duration of illness. The
tin decrease in mature cross-links of skin elastin
no- in ALS patients during illness takes place
as more rapidly than would be expected in nor-
kin mal ageing.
Fullmer et all found degenerative elastic
tissues and fragmentation of elastic fibres
with altered collagen bundles in the skin of
ALS patients. Stortebecker et al,'2 who stud-
ied biopsied samples of the temporal artery in
12 ALS patients and nine age-matched con-
trols, showed that discontinuities, splitting,
and multiple fragments of the internal elastic
membrane were observed more frequently in
ALS patients than in controls. These changes
are considered to reflect normal ageing
processes,13 suggesting that morphological
changes caused by the ageing process in the
elastic component occur more quickly in ALS
patients than in controls. The biochemical
B data presented in this report are consistent
with these morphological findings in ALS
patients.
The content of desmosine in various
elastin preparations has been shown to be
fairly constant.'4 Consequently, assay of
desmosine and isodesmosine, which account
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amino acids, respectively, can be used as a
measure of the amount of elastin in tissues.'4
Based on this assumption, it is likely that
there is a marked decrease in-the content of
elastin in the skin of patients with ALS.
Because the immediate precursors of desmo-
sine and isodesmosine are not known, it is
not possible at present to ascertain whether
these precursors increase as desmosine and
isodesmosine decrease, in a manner similar to
HHL cross-linking in collagen ofALS skin.6
The presumed mechanism of elasticity of
tissues is based on the continuity of the net-
work of elastin polypeptides interconnected
by stable cross-linkages predominantly in the
form of desmosine and isodesmosine.
Alterations in the supramolecular organisa-
tion of the elastic fibre network could lead to
mechanical alterations in the skin, which
would manifest as wrinkled, loose, and sag-
ging skin, as noted during cutaneous ageing.'5
In support of this concept are several observa-
tions made on patients with either inherited
or acquired cutaneous diseases with elastic
fibre abnormalities. Cutis laxa is charac-
terised by decreased elasticity of skin due to a
decrease in skin elastin detected by reduced
desmosine content, and stretching of the skin
of this disease produces delayed recoil.'6 The
skin of ALS patients in its late stage loses
elasticity.SA When the skin is stretched, it
returns very slowly to its original position
("delayed return phenomenon"),24 similar to
that found in cutis laxa."5 Accordingly, a
marked decrease in the amount of elastic
fibres in the skin of ALS could well explain
this specific clinical finding ofALS patients.
This work was partly supported by NIH grants DE 08522,
DE 08611, AR 19969, AR 30587, and NASA grant NAG-2-
181.
We thank Dr David L McIlwain of the Department of
Physiology of the University of North Carolina at Chapel Hill
for his valuable comments and encouragement, and Dr
Theodore A Walter and Mr Z Haque for their technical assis-
tance.
1 Fullmer HM, Siedler HD, Krooth RS, Kurland LT. A
cutaneous disorder of connective tissue in amyotrophic
lateral sclerosis: a histochemical study. Neurology 1960;
10:717-24.
2 Ono S, Toyokura Y, Mannen T, Ishibashi Y.
Amyotrophic lateral sclerosis: histologic, histochemical,
and ultrastructural abnormalities of skin. Neurology
1986;36:948-56.
3 Ono S, Toyokura Y, Mannan T, Ishibashi Y. "Delayed
return phenomenon" in amyotrophic lateral sclerosis.
Acta Neurol Scand 1988;77:102-7.
4 Ono S, Mannen T, Toyokura Y. Differential diagnosis
between amyotrophic lateral sclerosis and spinal muscu-
lar atrophy by skin involvement. J Neurol Sci 1989;91:
301-10.
5 Ono S, Mechanic GL, Yamauchi M. Amyotrophic lateral
sclerosis: unusually low content of collagen in skin.
J Neurol Sci 1990;100:234-7.
6 Ono S, Yamauchi M. Collagen cross-linking of skin in
patients with amyotrophic lateral sclerosis. Annu Neurol
1992;31:305-10.
7 Piez KA. Cross-linking of collagen and elastin. Annu Rev
Biochem 1968;37:547-70.
8 Starcher BC, Percival S. Elastin turnover in the rat uterus.
Connect Tissue Res 1985;13:207-15.
9 Francis G, John R, Thomas J. Biosynthetic pathway of
desmosines in elastin. Biochem3J 1973;136:45-55.
10 Gunja-Smith Z, Lin J, Woessner JF. Changes in desmo-
sine and pyridinoline crosslinks during rapid synthesis
and degradation of elastin and collagen in the rat uterus.
Matrix 1989;9:21-7.
1 1 John R, Thomas J. Chemical compositions of ela6tins iso-
lated from aortas and pulmonary tissues of humans of
different ages. Biochem J 1972;127:261-9.
12 Stortebecker P, Nordstrom G, Pesteny MP, Seeman T,
Bj6rkerud S. Vascular and metabolic studies of amy-
otrophic lateral sclerosis: angiopathy in biopsy speci-
mens of peripheral arteries. Neurology 1970;20:1157-60.
13 Crawford ST. Blood and lymphatic vessels. In: Anderson
WAD, Kissane JM, eds. Pathology, vol 1, 7th edn. Saint
Louis: Mosby, 1977:879-927.
14 Starcher BC. Determination of the elastin content of tis-
sues by measuring desmosine and isodesmosine. Anal
Biochem 1977;79:11-5.
15 Uitto J. Connective tissue biochemistry of the aging der-
mis: age-related alterations in collagen and elastin.
Dermatol Clin 1986;4:433-46.
16 Hashimoto K, Kanzaki T. Cutis laxa: ultrastructural and
biochemical studies. Arch Dermatol 1975;111:861-73.
96
